Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
On the earnings call, Okupe said the company expects $725 million of its $2.3 billion to $2.4 billion in revenue this year to come from weight-loss drugs
Hims & Hers currently promotes Zepbound, an FDA-approved tirzepatide product, starting at $299 for medication
Watch Your Waist Shrink When cravings and overeating are under control, the weight finally starts coming offand stays off
15 Payers are currently reeling from the financial impact of GLP-1 prescriptions
The MoodMotivation Connection Many people experience a dip in mood when daylight decreases
The bridge program explicitly lifts the anti-obesity medication exclusion for qualifying patients
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
